Lendormin D® Tablet (Drug Use Result Survey)

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Study to investigate the safety and the efficacy in patients with insomnia, receiving Lendormin D tablet under condition of normal clinical practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Brotizolam

Criteria

Inclusion Criteria:

• Patients with insomnia

Exclusion Criteria:

• none